Price Point Analysis for Laboratory Developed Tests (LDTs) and FDA Regulated Tests
Price Point Analysis for Laboratory Developed Tests (LDTs) and FDA Regulated Tests
Discover the Perfect Assay Price Point to Remain Competitive
12-Sep-2016
North America
Description
The main objective of this research is to estimate test volumes and unit prices for a wide variety of LDTs (genetic) and a few high volume FDA tests for selective therapeutic areas. The tests are categorized by their intended uses across the diagnostic spectrum (risk assessment, screening, diagnosis, staging and prognosis, therapy selection, therapy monitoring). A selective list of therapeutic areas covered in this research include: autoimmune diseases, cancers (breast, colorectal, prostrate, lung, gastric, cervical, and ovarian), toxicology, cardiology, women’s health (vitamin D, prenatal, pregnancy and hormone), and infectious disease testing (TB, hepatitis A/B/C, cytomegalovirus). The base year used for analysis is 2015.
Table of Contents
Research Scope
Executive Summary
Executive Summary (continued)
Executive Summary (continued)
Research Objectives
Abbreviations
Celiac Disease Specific LDT Assays
Chron’s Disease Specific LDT Assays
Rheumatoid Arthritis Specific LDT Assays
Lupus Specific LDT Assays
LupusSpecific LDT Assays (continued)
IBD and IBS Specific LDT Assays
Biomarker Guidelines
Cardiac Disease Specific LDTs and FDA Assays
Cardiac Disease Specific LDTs and FDA Assays (continued)
Prostate Cancer Specific LDT Assays
Prostate Cancer Specific LDT Assays (continued)
Breast Cancer Specific LDT Assays
Breast Cancer Specific LDT Assays (continued)
Breast Cancer Specific LDT Assays (continued)
Colon Cancer Specific LDT and CLIA Waived Assays
Colon Cancer Specific LDT and CLIA Waived Assays (continued)
Colon Cancer Specific LDT and CLIA Waived Assays (continued)
Lung Cancer Specific LDT and FDA Assays
Lung Cancer Specific LDT and FDA Assays (continued)
Gynecologic Cancers (Ovarian)Specific LDT and FDA Assays
Gynecologic Cancers (Cervical)Specific LDT and FDA Assays
Biomarker Guidelines
Gastric Cancer/GIST Specific LDT and FDA Assays
Women’s Health Vitamin D Tests
Women’s Health Prenatal Tests
Women’s Health Pregnancy and Hormone Tests
Toxicology Popularly Ordered Tests
Infectious Diseases Popularly Ordered Genetic Tests
Infectious Diseases Popularly Ordered Tests
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition—Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Popular Topics
No Index | No |
---|---|
Podcast | No |
Author | Divyaa Ravishankar |
Industries | Healthcare |
WIP Number | 9AB9-00-55-00-00 |
Is Prebook | No |